Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Latest From Alvotech

Alvotech Adalimumab Biosimilar Switching Study Hits Key Date

Alvotech underlined that it could “save US consumers and taxpayers billions annually,” after hitting a key landmark in its Phase III switching study for its high concentration 100mg/ml biosimilar Humira product.

Biosimilars Clinical Trials

AbbVie Sues Alvotech Again Alleging At-Risk Adalimumab Launch

In the latest twist in the tussle between Alvotech and AbbVie over Humira intellectual property, the originator has sued the Icelandic firm for a second time in a court in Illinois, in an attempt to enforce almost 60 patents that it says Alvotech has previously declined to litigate.

Biosimilars Intellectual Property

Alvotech Attacks AbbVie Over Adalimumab

Alvotech has launched a US legal challenge over intellectual property around AbbVie’s Humira, claiming that the company enjoys a “wrongful monopoly” on the top-selling arthritis treatment for which the biosimilars company is developing a high-concentration adalimumab rival.

Biosimilars Intellectual Property

Alvotech Hits Back Over Humira Trade Secrets Accusations

Alvotech has issued a robust rebuttal of accusations that it obtained AbbVie trade secrets relating to Humira for use in developing its biosimilar adalimumab rival.

Legal Issues Biosimilars
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Biotechnology
    • Synthesis Technologies, Production Processes
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Alvotech Iceland
    • Alvotech Germany GmnH
    • Alvotech Swiss AG
    • Glycothera